Physician profile
Evan Lytle
NPI 1932582269
$3,097.34
in general payments reported to CMS, 2019-2025
10 companies · $643 in 2025
The $643 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $120 · 2021: $403 · 2022: $90.66 · 2023: $1,728 · 2024: $113 · 2025: $643.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,579 · Food and Beverage: $904.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,579.41 |
| Food and Beverage | $904.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,756.36 | 2022-2025 | Everest Spinal System, Prolift, Yukon Oct Spinal System |
| Alphatec Spine, INC | $632.00 | 2023-2025 | Other - Miscellaneous, Invictus Mis, Battalion Tlif - PC |
| Novocure INC. | $139.86 | 2021 | |
| Centinel Spine, LLC | $133.00 | 2021 | |
| Medical Device Business Services, INC. | $129.99 | 2021 | |
| Zimmer Biomet Holdings, INC. | $120.00 | 2019 | |
| Medtronic, INC. | $112.76 | 2022-2025 | Intellis Adaptivestim, Rialto Si Fusion System, O-Arm |
| Abbott Laboratories | $28.85 | 2025 | Proclaim |
| Kuros Biosciences USA, INC | $22.87 | 2025 | Magnetos |
| Davol INC. | $21.65 | 2025 | Surgiphor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Evan Lytle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.